IRIS
MONTOMOLI, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.434
NA - Nord America 14.344
AS - Asia 6.642
SA - Sud America 1.503
AF - Africa 168
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 37.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.147
GB - Regno Unito 4.934
RU - Federazione Russa 2.891
CN - Cina 2.419
SG - Singapore 2.080
IE - Irlanda 1.759
IT - Italia 1.436
BR - Brasile 1.280
UA - Ucraina 825
SE - Svezia 774
HK - Hong Kong 604
DE - Germania 597
FR - Francia 519
VN - Vietnam 507
KR - Corea 454
FI - Finlandia 326
IN - India 173
AR - Argentina 99
CA - Canada 91
BD - Bangladesh 68
MX - Messico 63
ES - Italia 57
AT - Austria 55
PL - Polonia 51
TR - Turchia 51
CI - Costa d'Avorio 49
NL - Olanda 48
ZA - Sudafrica 46
IQ - Iraq 43
JP - Giappone 40
BE - Belgio 38
EC - Ecuador 33
CZ - Repubblica Ceca 25
ID - Indonesia 23
PK - Pakistan 22
CO - Colombia 20
MA - Marocco 20
VE - Venezuela 18
LT - Lituania 17
UZ - Uzbekistan 17
PY - Paraguay 15
PE - Perù 14
AU - Australia 13
IL - Israele 13
IR - Iran 12
JM - Giamaica 12
EG - Egitto 10
HU - Ungheria 10
JO - Giordania 10
MY - Malesia 10
SA - Arabia Saudita 10
OM - Oman 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
BG - Bulgaria 8
KZ - Kazakistan 8
CH - Svizzera 7
CL - Cile 7
KG - Kirghizistan 7
NG - Nigeria 7
TN - Tunisia 7
AM - Armenia 6
DK - Danimarca 6
KE - Kenya 6
AL - Albania 5
BO - Bolivia 5
DZ - Algeria 5
GR - Grecia 5
LB - Libano 5
LU - Lussemburgo 5
LV - Lettonia 5
RO - Romania 5
BY - Bielorussia 4
CR - Costa Rica 4
EU - Europa 4
GT - Guatemala 4
PH - Filippine 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CG - Congo 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
Totale 37.070
Salva come PNG Salva come JPEG
Città #
Southend 4.623
Dallas 2.241
Dublin 1.741
Fairfield 1.471
Singapore 1.129
Ashburn 995
Chandler 987
Moscow 809
Santa Clara 796
Woodbridge 710
Jacksonville 683
Houston 601
Hong Kong 599
Beijing 586
Wilmington 566
Seattle 559
Cambridge 470
Hefei 454
Siena 436
Seoul 435
Ann Arbor 406
Princeton 282
Nanjing 229
Dong Ket 189
Los Angeles 188
Munich 145
The Dalles 127
San Mateo 118
San Diego 117
Ho Chi Minh City 116
Helsinki 115
Boardman 114
Buffalo 109
Council Bluffs 103
Milan 100
São Paulo 94
New York 87
Nanchang 74
Lappeenranta 73
Bengaluru 72
Hanoi 71
Redondo Beach 71
Florence 68
Rome 68
Shanghai 60
Shenyang 55
Tianjin 51
Abidjan 49
London 49
Nuremberg 47
Chicago 44
Columbus 44
Hebei 42
Warsaw 41
Rio de Janeiro 39
Brussels 37
Málaga 37
Phoenix 37
Changsha 36
Tokyo 36
Toronto 36
Kunming 35
Jiaxing 33
Jinan 29
Norwalk 29
Vienna 29
Brooklyn 28
San Francisco 28
Hangzhou 27
Johannesburg 26
Montreal 26
Dearborn 25
Guangzhou 25
Stockholm 25
Belo Horizonte 24
Portsmouth 24
Atlanta 23
Baghdad 23
Brasília 23
Brescia 23
Düsseldorf 23
Frankfurt am Main 23
Turku 23
Mumbai 22
Denver 21
Orem 20
Redwood City 20
Boston 18
Da Nang 18
Lancaster 18
Livorno 18
Ningbo 18
Poplar 18
Porto Alegre 18
Bra 17
Chennai 17
Curitiba 17
Lauterbourg 17
Ribeirão Preto 17
Zhengzhou 17
Totale 25.652
Salva come PNG Salva come JPEG
Nome #
A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses 583
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014 567
The virucidal potential effects of violet-blue light on influenza D virus 519
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions 516
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza a(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project 473
Single dose vaccination of the ASO3-adjuvanted A (H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains 469
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy 467
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017 446
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy 397
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 330
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 323
Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in mice 297
Egg-Independent Influenza Vaccines and Vaccine Candidates 297
Influenza anti-stalk antibodies: Development of a new method for the evaluation of the immune responses to universal vaccine 270
A method for detection of neuraminidase antibody in serum 265
Flucelvax (Optaflu) for seasonal influenza 257
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 257
Challenges in the development of egg-independent vaccines for influenza 255
Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 - 2018 season 246
Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination 245
Age and influenza-specific pre-vaccination antibodies strongly affect influenza vaccine responses in the icelandic population whereas disease and medication have small effects 237
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses 236
Emerging influenza strains in the last two decades: A threat of a new pandemic? 233
N. meningitidis and TLR polymorphisms: A fascinating immunomodulatory network 229
Moderate vaccine effectiveness against severe acute respiratory infection caused by a(H1N1)pdm09 influenza virus and no effectiveness against a(H3N2) influenza virus in the 2018/2019 season in Italy 229
A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines 228
Neisseria meningitidis infection: Who, when and where? 226
An unwanted guest: Neisseria meningitidis–carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence 224
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production 224
A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly. 223
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 223
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 222
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children 221
Influenza immunology evaluation and correlates of protection: a focus on vaccines 220
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: Awareness warranted for 2017/18 season 215
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice 213
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates 212
How much ozone bactericidal activity is compromised by plasma components? 210
Early rise of blood T follicular helper cell subsets and baseline immunity as predictors of persisting late functional antibody responses to vaccination in humans 210
A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine 208
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 208
Immunogenicity and safety of the new inactivated quadrivalent influenza vaccine vaxigrip tetra: Preliminary results in children ≥6 months and older adults 207
Swine influenza and vaccines: an alternative approach for decision making about pandemic prevention 202
Fighting Neisseria meningitidis: past and current vaccination strategies 201
Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses 200
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 199
Cost-benefit evaluation of anti-influenza vaccination in the elderly during two influenza seasons in the Siena district [Valutazione benefici-costi della vaccinazione antinfluenzale negli anziani in due stagioni epidemiche a confronto nella provincia di Siena] 197
A Cell Culture (Vero)–Derived H5N1 Whole-Virus Vaccine Induces Cross-Reactive Memory Responses 196
Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines 195
Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study 192
A clinical trial of a whole-virus H5N1 vaccine derived from cell culture 192
Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza 190
Retrospective Study Evaluating Seroprevalence of Hepatitis E Virus in Blood Donors and in Swine Veterinarians in Italy (2004) 189
RT-PCR multiplex per l’identificazione simultanea di influenza virus A/H1N1 A/H3N2 e B e Virus Respiratorio Sinciziale di tipo A e B 185
Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge 185
Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period 184
Impact of erythrocyte species on assays for influenza serology 183
Measles in pregnancy: a threat for Italian women? 181
Mapping host-related correlates of influenza vaccine-induced immune response: An umbrella review of the available systematic reviews and meta-analyses 181
Overview of serological techniques for influenza vaccine evaluation: Past, Present and Future 180
Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group? 179
Influenza vaccines: Evaluation of the safety profile 179
Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence 177
CORRELATES OF PROTECTION AND HOST-RELATED MODIFIERS OF THE IMMUNOGENICITY OF INFLUENZA VACCINES: EVIDENCE MAPS AND EVIDENCE GAPS 175
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 174
Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy 173
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 171
Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells 169
Live attenuated influenza vaccine in children induces b-cell responses in tonsils 169
Controllo dell'attività sterilizzante di un nuovo tipo di autoclave per uso odontoiatrico. 169
Chlamydia pneumoniae and angiographically demonstred coronary artery disease in sample population from Italy 169
Pre-emptive vaccination against pandemic influenza virus 168
Hepatitis A infection in central Tuscany in children and youths 168
Safety, tolerability and immunogenicity of a mammalian cell culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial 168
Vaccination against Hepatitis B - Lenght of protection among populations at risk 165
Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses 165
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 165
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine 164
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza 164
Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations 163
Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania 163
Expression of sialic acid influenza receptors in red blood cells from avian and mammalian species: an immunological comparative study 162
Discordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals 162
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019? 162
Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9-year period 161
Swine influenza and vaccines: an alternative approach for decision making about pandemic prevention 161
The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants 160
Sea buckthorn bud extract displays activity against cell-cultured Influenza virus 159
International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE 158
Hepatitis A seroprevalence in Tuscany, Italy 157
Immunity to measles in Italian children and adolescents: a persistent problem in view of measles elimination 155
Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004 154
Epidemiologia e prevenzione delle malattie dentali a Siena: studio pluriennale (1988-1996) su campioni di alunni della scuola dell'obbligo. 154
Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic 153
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 153
Cross subclade immunity after one-year booster immunization with MF59®-adjuvanted A/H5N1 influenza vaccine in 6 month to 17 year-old children 152
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples 152
Tick-borne encephalitis: the impact of epidemiology, changing lifestyle, and environmental factors. Conference report of the 12th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE) 151
Medicine use and recurrent complaints among 15-years-old adolescents in Tuscany 151
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains 151
Totale 22.294
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.103
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.977 0 0 0 0 0 503 220 565 369 530 359 431
2021/20222.653 236 394 263 233 100 75 115 174 164 214 225 460
2022/20233.333 201 296 402 480 311 666 90 299 344 62 111 71
2023/20242.547 86 75 187 110 101 589 981 75 27 111 38 167
2024/20256.417 160 386 611 352 727 424 221 368 569 286 652 1.661
2025/202610.002 1.271 2.069 2.031 1.866 2.630 135 0 0 0 0 0 0
Totale 37.664